Loader
CORONA VIRUS

Questions

SARS-CoV2 Testing

NEUTRALISING ANTIBODY (IMMUNITY) TESTING

Why is there no distinction – especially in public health information and testing – between SARS-Cov-2 and Covid-19?

  • SARS-CoV-2 is the coronavirus and it is susceptible to antivirals and prevention measures (prophylactics)
  • Covid-19 is the immunological consequence of contracting the coronavirus and it may require treatment
  • Covid-19 severity is measured by hypoxia and biochemical and immunological indicators (CRP, D-Dimer etc)
  • TEST TYPES

  • The quantitative IgG antibody test selectively detects antibodies directed against the protein S at the spike of the virus. Since all the vaccines currently in use are addressing this specific protein S, the test allows to adequately measure the human immune response resulting from vaccination as well as immune responses resulting from a prior infection. The test can be performed after recovery and any time during the vaccination period but is recommended after 2-3 weeks post vaccination.
  • Cellular immunity tests, on the other hand, isolate immune cells and stimulate them with spike proteins of the virus. This enables measurement of the amount and activity of T-Cells, which are responsible for eliminating ill or altered cells. T-Cells together with antibodies make up the human immune response. Therefore, cellular immunity tests are complementary to antibody tests.
  • PROPER TESTING

  • Proper testing shows up individual immunity (T-cells & antibodies) resistance to SARS-CoV2
  • Testing is non-discriminatory
  • Anything less than proper testing is increasing risk to public health
  • Anything less than full spectrum testing is perpetuating the virus
  • If testing is not free, testing will happen less for poor people, perpetuating the virus
  • If testing is not standardised, test results will not give consistent data, perpetuating the virus
  • If testing protocols are not comprehensive, along with other public health management, SARS-CoV2 will become endemic
  • COVID-19 testing turns to T cells (12-May-2021)
  • The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity (21-Oct-2021)
  • Verifying immunity – SYNLAB helps people to monitor their immunity status after vaccination against and recovering from SARS-CoV-2 (Mar-2021)
  • Doctors Laboratory: Coronavirus Covid-19 PCR/Antibody Testing
  • Why is resistance to SARS-Cov-2 and Covid-19 testing and policy so remedial?

  • B-cell/T-cell and neutralising antibody testing – the complete trinity – is definitive
  • Lack of testing networks speak to unprecedented confusion or obfuscation in pandemic response and public health messaging
  • T-B-nA combination testing shows high and long lasting from natural immunity but these levels partly depend on viral load exposed
  • Vaccine immunity is demonstrated T-nA but less convincing on long-term memory B-cell stimulation
  • Vaccines give a more definitive high equivalent viral load so can stimulate less variable antibody and T-cell response than – for example – low viral load natural exposure
  • Why is there no publicly available data on T-B-nA levels for natural immunity, for vaccine immunity, for combined vaccine+natural and natural+vaccine immunity?
  • Lack of public data subordinates policy to political agenda, which can be self-serving
  • There’s no public data tracking people who were in the vaccine trials (completions or terminations)
  • There’s no public data tracking cases (infections) in key demographics as T-B-nA levels wax and wane
  • There is no public data tracking vaccine induced T-B-nA levels over time
  • Why the fuck aren’t these tests and why isn’t this data being collected/made available? It is a criminal failure of public health management
  • INFRASTRUCTURE

  • Why has there been so little emphasis and such a lack of progress on testing and testing infrastructure from early 2020 to today?
    • Rapid T-B-nA testing
    • Rapid public peer-reviewable results
    • Judiciously placed testing points (e.g. at schools, malls, public transport interchanges, etc)?
    • Free testing as a public health priority
    • Free treatment if testing results show infection and high risk
    • Proper testing has 100% demonstrable benefits
    • Proper testing has no downside except cost to government and shifting the needle away from purely political public health policy
    • WHO PAYS?

    • Polling shows even the vaccine hesitant are not against regular testing if it’s free and especially if it’s a test they can take at home
    • In economic terms, testing is surely cheaper than potentially bankrupting disruption of sledgehammer lockdowns – cost benefit analysis makes this clear
    • The major difference between focus on testing and fixation on lockdown is who pays:
      • Testing infrastructure is paid for by government
      • Lockdowns are paid for by the individual citizens and small business owners

      PANDEMIC CLARITY

    • How can there be no pandemic test-and-trace – or at least test-and-advise – protocol?
    • How can governments (and institutions) argue endlessly over mask mandates in schools, vaccinating children, lockdowns, freedoms curtailed, quarantines, travel restrictions, when these could be settled by an open, logical, follow-the-data decision making?
    • Testing doesn’t need to be welded to tracking if the link creates public discontent
    • There’s a wilful repetition of the presumption testing must always include tracking that’s too consistent to be accidental
    • Test-and-trace (instead of simply comprehensive T-B-nA testing) distracts public scrutiny away from REAL government failure (or refusal) to fund simple provision of comprehensive testing infrastructure by instead stoking fear of future abuse (tracking surveillance)
    • VACCINE IMMUNITY

    • Given the vaccination objective is to get the immune system to work up antibodies against exposure to Sars-COV2, why’s there no tracking of antibody response in those who’ve been vaccinated, those who’ve recovered from Covid-19, etc?
    • Shouldn’t that be the basis for vaccine need?
    • Wouldn’t it also create a non-judgmental way to encourage vaccine hesitant to get the shot?
    • TESTING IMMUNITY

    • Why do none of the Covid-19 testing protocols include the full spectrum of spike protein antibody + aggressive T-cell + memory B-cell scores?
    • Why is there almost no coherent variant tracking?
    • Why is there no public data on variant tracking?
    • Why is a negative Covid-19 test + high T-B-nA score not equivalent (or better) to vaccination certification?
    • How can a vaccine passport be better than a sufficient up to date T-B-nA test?
    • People’s response to vaccine will vary. Some vaccinated are superspreaders, even if it’s less than unvaccinated
    • Antibody testing would target elimination of Covid-19, which is what we want eliminated, rather than simply targeting the exclusion of unvaccinated, which won’t necessarily limit viral infections
    • Antibodies/T-Cells/B-cells numbers are the measure of immune system successfully responding, either to vaccine or to past infection or to both. Individual T-B-nA tests results can’t be faked, unlike vaccine certificates or vaccine passports or limited nA only tests
    • The antibody/T-cell/B-cell numbers are definitive, whereas an individual’s immune response to a vaccine will vary wildly so it defies logic to fixate on ‘got vaccine’ as a marker for individual immunity
    • Why wasn’t testing focused on antibody/T-cell/B-cell levels as soon as possible (April/May 2020) as it is also effective, useful data before vaccination (or infection)?
    • Antibody/T-cell/B-cell numbers show who has reacted well to vaccination, who may need boosters, who’s fought off SARS-CoV2 and acquired natural immunity, who may need vaccine despite a prior infection
    • Most important, the antibody/T-cell/B-cell immune system numbers show how safe a person is from being infected and/or infecting others with Coronavirus
  • Covid-19 Public Health Response

    SUMMARY

    • Vaccines, obviously
    • Aspirated vaccination standard
    • Proper testing and fast response to positive tests
    • Unshackled doctor-prescribed prophylactics and other treatments per doctor patient relationship
    • Particular care for immunocompromised people in particular with a full range of prophylactics
    • Individual health and individual immune system aids: vitamin D, Zinc, weight loss, less smoking, cardiovascular exercise, etc etc

    COVID VACCINE (and PROPHYLAXIS) AIM?

    • Immunity to SARS-CoV2 + protection against Covid-19
      • Antibodies against SARS-CoV2
      • Stimulate B-cells
      • Educate T-cells
    • Reduce SARS-CoV2 viral load
    • Shorten period of SARS-CoV2 infectiousness
    • Less likely to be hospitalised by Covid-19
    • Less likely to die from Covid-19
    • Vaccination gives non-0 immunity boost without having to risk contracting the Covid-19
    • Infection of SARS-CoV2 produces natural immunity with associated risks

    NATURAL v VACCINE IMMUNITY

    • Recovering from the virus gives 8x-12x level of antibody immunity
    • SARS equivalent immunity has lasted 10+ years
    • mRNA vaccine immunity is shown to wane considerably after 6 months

    ASPIRATION!

    • Why is there no official protocol for aspirating before injection of vaccine, to ensure none of the vaccine is intravenous?
    • Aspirating ensures vaccination goes intramuscular, not intravenous. Intravenous is dangerous
    • Intravenous doesn’t happen often but it is more common in younger people
    • Lack of aspiration is the prime candidate for what could be causing the relatively rare but nonetheless real adverse reactions
    • Significant incidents of post-vaccine myocarditis, thrombosis and other extreme adverse reactions to the mRNA vaccines in particular

    PUBLIC HEALTH

     

    COMORBIDITIES

    Why no public health messaging on tackling known comorbidities like weakened immune system or obesity etc?

    • Why is there no broadcast messaging about immune system healthiness, like Vitamin D, Zinc, obesity, smoking, judicious diet, fitness, or proven cheap Covid-19 prophylactic nasal spray/eye drops?
    • It makes no medical sense whatsoever not to frontline these easy personal interventions likely to save tens of thousands of lives (at the very lowest)

     

    ARTICLES / STUDIES

     

    Masks - Mask Mandates

    18+ months into pandemic, how can there be no definitive public health protocols for mask use?

     

    Why is there almost no thorough study data on masking, mask policy or airflow viral load?

     

    Why has the study of masking been allowed to be a merely political / civic law enforcement wedge issue?

    • Public health should be organised as a medical issue regardless of which “team” is in power
    • There should surely be no uncertainty about these basic issues
    • The next pandemic may be worse

     

    ARTICLES / STUDIES

    • Exactly
    Prophylaxis and Treatment Protocols
    Why is there zero definitive info on medical prophylaxis? Why no policy on individual prevention? Why no open debate on evolving treatment protocols?
    • Much talk about cases of damage from the spike protein post-vaccine but reasons have been hard to pinpoint. Could it be down to not asperating the needle prior to injection, and thus occasional inadvertent injection of the vaccine into the bloodstream – which is known to be extremely dangerous?
    • How many who’ve had the vaccine got their needles aspirated?
    • Why would there be aggressive, partisan exclusion of ANY prophylactic that’s cheap and universal and proven safety record?
    • Amplifying overdose victims is propagandist; never sincere.
    CONSIDERATIONS
    • vaccine gives (high estimate) 90% protection from SARS-Cov2
    • ivermectin prophylactic + treatment inclusion adds 0%-5% protection (i.e. it is useless or it is a bit useful)
    • end result potentially saves tens of thousands of lives WITH the antiviral versus withou
    • no downside to using all possible probable non-harmful preventions,m treatments, etc
    • Where’s the medical logic in banning ivermectin or predisposing against any medication promising even a single percentage better outcome likelihood?
     
    • Is the dosage level required to get enough ivermectin into play for anti-Sars-CoV2 viral replication significant? Because Pfizer’s last line of defense for its ritonivir combo drug (that works like ivermectin) is it needs a much lower (safer) dosage to be effective as an anti-SARS-CoV2 protease inhibitor
    • Could this be because while Ivermectin inhibits many mechanisms (as you’ve reported), this makes it less effective – by dose – against any one specific mechanism? Might this require higher dose Ivermectin to be as effective as Pfizer’s Paxlovid, which targets only one mechanism?
    • (Even though obviously the Pfizer drug is far more likely to become resisted by viral mutation as it is single mechanism rather than Ivermectin’s multiple mechanisms of action)
    • Is the dosage per mechanism significant? I’ve not yet found a paper answering this question!
    Covid Vaccines - Vaccine Mandates

    VACCINE PROS AND CONS

    • Reduces likelihood of hospitalisation (and worse) for elderly, comorbidities and immunocompromised – which is the majority of the population
    • Vaccine efficacy against Covid-19 – especially hospitalisation and life-threatening complications – remains demonstrable even for young people, unless specifically at risk
    • Antibody levels in part come from extent of viral load exposed
    • Passing natural infection might engender lower antibodies than a double or triple (i.e. regular) dose of vaccine
    • Natural immunity is absorbed into long-term B-cell memory as mRNA inspired response does not
    • Systemic side-effects from vaccine especially mRNA vaccine more common in people previously infected

     

    ADVERSE REACTIONS

    The Story of Kyle Warner – Pro-Mountain Biker

    VACCINES FOR YOUNG AND OLD

    • Reduces likelihood of hospitalisation (and worse) for elderly, comorbidities and immunocompromised – which is the majority of the population
    • Vaccine efficacy versus Covid-19 remains pro-vaccine even for young people, unless specifically at risk
    • Young have greater risk from vaccination versus older people risk from coronavirus. Who deserves to take the risk?
    • Young people recover fast
    • Young males risk greater from mRNA vaccination than from Covid-19
    • Should young people be forced to take the individual risk for the sake of older, vulnerable members of the public?
    • Myocarditis young – especially young males – incident percentages higher than simply catching Covid and higher than baseline in population – but this might be a consequence of omitting aspiration?

    VACCINE MANDATES

    • CDC still recommends a full vaccination dose for everyone including young children
    • CDC recommends:
      • mandated boosters for all elderly
      • mandated for immunocompromised
      • mandated for frontline health workers and other public workers
      • recommends booster for all J&J single dose vaccinated
      • recommends boosters for all vaccinated after 6 months

    ARTICLES

    Immunity against SARS-CoV2

    IMMUNE RESPONSE

    • Immune response from vaccination is more predictable in short-term antibody responses
    • Immune response from vaccination plus prior infection provides highest level of antibody protection
    • Natural infection and vaccine efficacy  vary by individual and by viral load exposure
    • Breakdown:
      • B-CELL
      • T-CELL
      • Neutralising Antibodies
      • Different types of immune memory each had distinct kinetics, resulting in complex interrelationships over time:
      • Substantial immune memory is generated after COVID-19
      • About 95% of subjects retained immune memory at ~6 months after infection (natural immunity)
      • Circulating antibody titers were not predictive of T-cell memory
      • ECPDC: Immune responses and immunity to SARS-CoV-2

       

      IMMUNITY STUDIES

      • Natural infection data in the United States (Feb 2020 to May 2021):
        • 0 – 17     26.8 / 73    37%
        • 18 – 49   60.5 / 138   44%
        • 50 – 64     20.4 / 62    32%
        • 65+ 12.3 / 54    23%
        • Total 120.3/ 328   37%
      • N = 254 blood samples post infection
      • N = 51 long term follow up
      • Antibodies against SARS-CoV2 spike and receptor binding domain (RBD) declined moderately over 8 months
      • Memory B cells against SARS-CoV2 spike increased between 1 week and 8 weeks after infection
      • Proportion of subjects positive for CD4+ T cells (92%) remained high at 6 to 8 months after infection

       

      NATURAL / VACCINE IMMUNITY

    • Natural infection provides immunity to SARS-CoV2
    • Natural immunity lasts longer but short-term may not be as strong as vaccine immunity
    • mRNA vaccine causes higher short-term immunity response to coronavirus but wanes after 3-6 months
    • adenovirus vector vaccines not as high  as mRNA short-term but as a more traditional mechanism the protection wanes slower
    • UK covid pass guidelines taking into account immunity
    • France and other European countries test for neutralising antibodies which is accepted as vaccine equivalent (at least)
    • USA vaccine restrictions and vaccine mandate satisfied by proof only, no interest in antibodies – which is illogical
    • Vaccination was highly effective for 3-6 months after double dose:
      • Estimated efficacy for documented infection of 92·8%
      • Hospitalisation 94·2%
      • Severe illness  94·4%
      • Death   93·7%

     

    PRIOR INFECTION

  • Estimated efficacy for documented infection of  94·8%
  • Hospitalisation 94·1%
  • Severe illness  96·4%
  • MoH Summer Surge Data:
  • Between 5 July and 3 August (over half a million infected but unvaccinated)
  • Just 1% of weekly new cases were in people who had previously had covid-19 (99% natural immunity)
  •  

    PUBLIC HEALTH OFFICIALS:

    • Dvir Aran, Technion: “These numbers look very low. The data suggest that the recovered have better protection than people who were vaccinated.”
    • Peter Marks, FDA: “We know that the immunity after vaccination is better than the immunity after natural infection.”

     

    ARTICLES / STUDIES

    Lockdown and Quarantine

    HOSPITAL BURDEN

     

    Table of Contents

    Big Picture

    Public Trust - Government, Media, Health Authorities

    Why has public trust in government/media broken down? How can it be restored?

    • Why is government official guidance allowed to devolve into such useless disingenuous binaries?
    • Authoritarian binaries are idiotic and destroy public faith in institutions and institutional narratives
    • No party political narratives should exist in a pandemic
    • God-complex celebrity front-men like Dr Fauci, with compromised (and even corrupt) conflicts of interest private enrichment + personal fame + public duty
    • Vaccine versus anti-viral is a case in point. It’s not either vaccination or antiviral/alternative treatment. It’s both. It’s all of the above.
    • Statewide mandates restricting informed doctor-patient freedom of choice ensures both a fait accompli of outlier overdose while excluding billions (including those with no vaccine access) from best possible outcomes; not to mention demoralizing the medical profession at a time it needs to be supported
    • Why is there so much dehumanizing rhetorical and systemic pressure on the vaccine ‘hesitant’ to comply, but never anything substantial that might cost money, like a year’s free aftercare in the event of adverse reaction?
    • Fixation on compliance turns a public health choice into a loss of freedom fear, for much of the general public – why perpetuate this?
    • Vaccine makers are shielded from consequences in the event of negligence – how can this help public trust?
    • Why is there no quid pro quo support for workers who submit to testing and adhere to restrictions if infected (e.g. self-isolating), to cover loss of essential earnings?
    • Former HHS officials say they tried to accelerate funding for what became Merck’s new “miracle” drug last year, but were blocked by the NIH
    • Culture-war stupidity may have cost “tens of thousands” of lives

     

    REPORTAGE

     

    END JUSTIFIES MEANS?

    • Can the end justify the means when it come to public health, i.e. saving the most lives versus respecting individual freedom (to be wrong)?
    • Why is an anti-viral like Ivermectin pilloried as a “horse paste” – in such a blatantly propagandist, divisive way – despite its clear usefulness as a prophylactic, where it simply does what it’s proven to do, BEFORE mid/late stage infections take hold?
    • Some cite lack of quality data on anti-virals like Ivermectin as a reason for its aggressive exclusion from Sars-CoV2 protocols.
    • But then why wasn’t Ivermectin trial’d aggressively from early 2020, given it is cheap, readily available and proven to have an exemplary safety record in humans (e.g. against river blindness, dengue, etc)?
    Big Pharma - Pfizer, Moderna, AstraZeneca, J&J
    • Why so little attention given – especially from Summer 2021 – to data showing the ad-vector vaccine antibody response is lasting considerably longer than the Pfizer/Moderna mRNA shots?
    • Is the rapid loss of SARS-CoV2 neutralising antibodies (immunity) from – in particular – the mRNA vaccines contributing to the persistent and otherwise inexplicable low fidelity testing standards?
    • Why is AstraZeneca vaccine not available in the US, even after its proven safe, used in comparable countries with better Coronavirus outcomes?
     

    Is it possible for Big Pharma profit to coexist with best public health outcomes?

    • Why are new technologies like vaccine development largely funded by taxpayer spending, yet all profit goes to the shareholders of the pharmaceutical corporations?
    • Why is public health emergency subordinated to this upward wealth transfer profit dynamic, rather than the other way around?
    Vaccine Data - Trials - Efficacy - Apartheid

    Why did initial Pfizer/Moderna/AZ interim press releases define vaccine efficacy with no follow-up, no ongoing developing analysis or peer-reviewed results?

    • The initial vaccine trials, especially for Pfizer and Moderna, showed almost 100% efficacy but the real world has revealed lower efficacy and decreasing efficacy just 6 months into vaccination programs. Why is this acceptable, when non-mRNA vaccines don’t degrade this way?
    • The trial efficacy numbers for the vaccine phase 3 were extrapolated from, ultimately, just a few dozen cherry-picked subjects. How does  efficacy factor in time and viral load, i.e. spending more time coming into contact with SARS-CoV2, being exposed to higher viral load?
    • Vaccine trials pre-published their efficacy numbers after a few weeks phase 3 test subject data. Why were there no follow-up on those subjects involved in the various phase 3 trials, no ongoing testing status?

     

    BOOSTERS?

     

    VACCINE APARTHEID

    Is there vaccine apartheid in rich versus poor nations? Why won’t anyone break this paradigm?

    Antivirals - Ivermectin, Molnupiravir, Ritonavir

    QUESTIONS

    • Why is Merck putting billions into researching Molnupiravir patented antiviral without putting any resources into studies or proliferating proven safe Ivermectin off-patent antiviral with potential for repurposing against Covid-19?
    • Pharmaceutical companies are about business and profit, quite legitimately. But why is government not promoting existing treatments or funding studies – monoclonal antibodies, antiviral drugs (prophylaxis and/or treatment), etc – as a public health duty?  Why is government using its authority to push censorship in line with pharmaceutical company profit monopoly including making a fait accompli of emergency use authorisation and maximum profit from patent over off-patent generics?
    • How can corporate (big pharma) profit be more important than safeguarding human life in public health (government) decision making – funding – protocols – authorisations – recommendations – messaging – policy?

     

    WORLD HEALTH

    • There are still many nations where vaccines are not yet widely available.
    • There is a gradual shift in focus, to antiviral drugs.
    • Two ways to get new drugs:
      1. Develop novel antiviral drugs for SARS-CoV-2
      2. Repurpose existing FDA-approved drugs to treat COVID-19
    • Ivermectin (by Merck Pharmaceuticals) is the most studied “repurposed” medication globally in randomized clinical trials, retrospective studies and meta-analyses
    • Molnupiravir and Ivermectin have both demonstrated adjunctive chemoprophylaxis
    • No profit from generic off-patent Ivermectin
    • Funding from Merck (originally from NIH public funding) directed on:
    • New patented medication
    • Marketing Molnupiravir
    • Buying FDA-simpatico studies demonstrating Molnupiravir efficacy
    • Greasing the public health wheels for authorisation e.g. in the UK, US, EU, etc

     

    ONGOING TRIALS

    • Molnupiravir (Merck)
    • new prodrug antiviral developed by Merck Pharmaceuticals
    • currently in the pipeline for authorisation as a SARS-CoV2 prophylaxis and treatment
    • active treatment of new SARS-CoV-2 infections
    • post-vaccination breakthrough COVID-19 cases
    • authorised in the UK, applications pending USA and Europe
    • Ritonavir (Pfizer)
    • Phase 2/3 trials early completed
    • applying for authorisation

     

    PHARMODYNAMICS

    • “Molnupiravir is a pro-drug of the novel active antiviral nucleoside analogue … It’s a broad spectrum antiviral agent. … Ivermectin is a broad-spectrum, anti-parasitic, antibiotic and which has demonstrated broad-spectrum antiviral activity”
    • Molnupiravir is a broad spectrum antiviral agent against SARS-CoV-2, SARS-CoV, seasonal or pandemic influenza and MERS coronavirus
    • Ivermectin is an FDA-approved, WHO essential drug used as broad spectrum antiparasitic, antibiotic, and which has demonstrated broad spectrum antiviral activity against RNA viruses, including HIV, Zika, MERS and Coronavirus
    • FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
    • 5000-fold inhibition of SARS-CoV-2, (99.98% at 48 hours)
    • The inhibitory concentration IC50 of Molnupiravir shows it to be an even more potent anti-SARS-CoV-2 agent, compared to Ivermectin in vitro
    • Both Molnupiravir and ivermectin are well absorbed after oral dosing
    • Tmax of Molnupiravir being 1-1.75 hours, with a half life of 7 hours
    • Tmax of Ivermectin is 4-6 hours, very long half life of 81-91 hours
    • Ivermectin, being lipophilic has a large volume of distribution
    • Ivermectin has the ability to accumulate in the lungs where SARS-CoV2 is most dangerously concentrated
    • Anti-SARS-CoV-2 actions of Molnupiravir and Ivermectin are dose and concentration dependent
    • Molnupiravir active metabolite (NHC-5 Triphosphate) acts as a competitive alternative substrate for viral RNA causing viral mutagenesis or mutations, which leads to viral error catastrophe and extinction of replication
    • There is some concern about the safety of NHC -nucleoside triphosphate, which is also mutagenic to mammalian cells
    • Ivermectin, multifarious actions, binding to SARS-CoV-2 spike protein, reducing cell entry via human ACE2 receptors, reducing viral transcription
    • Complimentary pharmacokinetics and pharmacodynamics of the drugs may be additive or synergistic.
    • This should be further investigated in anti-SARS-CoV-2 antiviral combination therapy e.g. a combination of Molnupiravir with Ivermectin putatively, in effects on RdRP or cytokine release

     

    COST COMPARISONS

    • Cost of Ivermectin package of 100 tablets of 3mg is $2.96, e.g. 12mg per day for 5 days = $0.53
    • Cost of Molnupiravir to be negotiated separately with national health services but US govt initial purchase worked out at $700 for the equivalent 5 day course

     

    ARTICLES

     

    MOLNUPIRAVIR

     

    PAXLOVID (RITONAVIR)

     

    UNDERBELLY TIMELINE

     

    OBSERVATIONS

    • Risk of virus developing resistance to PF-07321332 means Pfizer’s proposed antiviral could be resisted whereas Ivermectin works on many levels
    • If Pfizer wanted to create a short-lived expensive patent medication that’d need a new patent medication as a perpetual profit opportunity for Pfizer

     

    IVERMECTIN STORY

    Antiviral medication Ivermectin was invented in Japan and mass-produced by Merck. It is now out of patent, cheap and available worldwide. Merck is developing Molnupiravir (MK-4482) as a therapeutic to treat COVID-19 infections. It would be an antiviral, like Ivermectin, but patented and therefore potentially worth tens of billions profit versus Ivermectin which is worth nada.

    Molnupiravir is in/recently finished Phase 3 trials. Merck received a base award amount of $1.2 billion on 7-Jun-2021 from the Federal Government (1.7 million doses). Molnupiravir is authorised by the UK health authority with authorisation pending in US FDA, EU, Canada and other cracker countries.

    Not surprisingly, the two antivirals have certain similarities. With neither showing any serious adverse side effects.

    Merck had the patent on Ivermectin until 1996. So it is not a coincidence that they have developed this very expensive drug, Molnupiravir, funded by the US taxpayer and which is similar. It follows, then, why there is so much disparagement of Ivermectin. If widely accepted, it could rain on Merck’s parade and greatly embarrass BARDA.

    What I cannot grasp is that for the 10 months when the vaccines were being developed, certain caring, critical care physicians sought out existing drugs and developed protocols. These have been changed multiple times and are currently undergoing more changes to address the variants issue. The FLCCC Alliance recommends the use Ivermectin as part of more expansive protocols which they have developed for the prophylaxis and treatment of COVID-19 at all stages by both the vaxxed and the un-vaxxed. These physicians should be lauded, not abused.

     

    IVERMECTIN MESSAGING

    Australian government pronounces on Ivermectin via new Australia Medical Association rules for all doctors. AMA rules specifically target doctors, restricting their prescribing, rather than citizens who may be buying antivirals on the black market.

    I doubt this new ruling will reduce illegal Ivermectin import. If anything the AMA dictates will push doctors and patients further apart, making the latter more likely to resort to self-prescribing, more likely to use social media for dosages, causing worse outcomes.

    The medically honest policy would’ve been to encourage the doctor-patient relationship by not mistrusting the medical experts and not alienating the patients. This would save lives by freeing doctors to nurture trust in vaccines (by recommending them) while antivirals or other additional interventions get prescribed (or not) under safe supervision.

    PANDEMIC TIMELINE

    2004-2019

       

    2020

     

    January 2020

    February 2020

    March 2020

    April 2020

    May 2020

    June 2020

    July 2020

    August 2020

    September 2020

    October 2020

    November 2020

    December 2020

     

    2021

     

    January 2021

    February 2021

    March 2021

    April 2021

    May 2021

    June 2021

    July 2021

    August 2021

    • “In vivo evidence that inadvertent intravenous injection of COVID-19 mRNA vaccines may induce myopericarditis. Brief withdrawal of syringe plunger to exclude blood aspiration may be one possible way to reduce such risk. Both Pfizer/BioNTech and Moderna have clearly stated that their vaccines should only be given via IM route. CDC/UK/WHO guidelines do not instruct this necessary technique.”

    September 2021

    October 2021

    November 2021

    PUBLIC HEALTH

    R&D

     

    BIG PHARMA

     

    SCIENTISTS

     

    PHARMACOLOGIES

     

    mRNA Tech

     

    GOVERNMENT

    • Public Readiness and Emergency Preparedness Act (PREP) (4-Oct-2021)
        • Note 1. Pursuant to 42 U.S.C. § 247d-6d the federal government “Declaration pursuant to section 319F-3 of the Public Health Service Act to provide liability immunity for activities related to medical countermeasures against COVID-19” provides that “manufacturers” of “any vaccine, used to treat, … prevent or mitigate COVID-19” shall enjoy “[l]iablity immunity ,” including, “from suit and liability under Federal and State law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a [COVID-19 vaccine].”
        • Note 2.  Pursuant to 42 U.S.C. § 247d-6d(c)(5) “If an act or omission by a manufacturer or distributor with respect to a covered countermeasure, which act or omission is alleged under subsection (e)(3)(A) to constitute willful misconduct, … such act or omission shall not constitute ‘willful misconduct’ … if—(i)neither the Secretary nor the Attorney General has initiated an enforcement action with respect to such act or omission; or (ii)such an enforcement action has been initiated and the action has been terminated or finally resolved without a covered remedy.

     

    Underbelly

    • DEFUSE PROJECT (22-Sept-2021)

      “Archive exposing timeline of gain-of-function circumvention of laws, appropriation of public funds, US-China secret collaboration and pandemic mishandling”

    • GAVI VACCINE (25-Aug-2021)

      “Scientists around the world are working to produce vaccines that can stop COVID-19 | since the emergence of this novel coronavirus in Dec 2019, 20 vaccines have started to be rolled out in countries worldwide”

    • BBC: TRUSTED NEWS INITIATIVE (10-Dec-2020)

      “Trusted News Initiative (TNI) brought to bear on news and internet media outlets, directed by government, ostensibly to combat so-called disinformation”

    • NIH: NIH VACCINE (25-Jun-2020)

      “NIH has played a critical role in coronavirus research for decades. Federal scientists have helped fund, design, patent and test mRNA-1273 and others; vaccine candidates developed through Moderna and licensed to BioNTech (Germany) partnered with Pfizer Inc”

    • Gain Of Function (19-Dec-2017)

      “National Institutes of Health (NIH) today lifted a 3-year moratorium on funding gain-of-function (GOF) research on potential pandemic viruses such as avian flu, bat coronavirus, SARS, and MERS, opening the door for gain-of-function research to resume”

    • Coronavirus Spike Protein (13-Oct-2017)

      “Prefusion Coronavirus Spike Proteins NIH document – exemplar of going through the motions of appropriating the govt-funded mRNA vaccine technology and corollary patents, to enrich private business interests”

    • Leading US Causes of Death 1999-2014

      “Studying the data about leading casues of death in metro and nonmetro areas of the United States 1999 and 2014 inclusive. Higher rates of death in nonmetropolitan areas (often referred to as rural areas) compared with metropolitan areas have been described”

    • 21st-Century CURES Act (13-Dec-2016)

      “The 21st Century Cures Act (Cures Act), signed into law on December 13, 2016, is designed to help accelerate medical product development and bring new innovations and advances to patients who need them faster and more efficiently – Ahem”

    • ACA Rural Health Insurance (29-Mat-2014)

      “Almost 50 million people (16%) population of the United States, live in rural areas, mainly low-to-moderate-income individuals. 65% of uninsured in rural areas live in States without ACA coverage”

    • Oxford Vaccine Docs Repository (Mar-2020 to Feb-2021)

      “Small repository of documents and links relating to the Oxford University SARS-CoV2 vaccine and Bill Gates Foundation early negotiations”

    • ECOHEALTH | Peter Daszak (2014-2019)

      “Ecohealth Alliance Inc (Peter Daszak) ongoing provision of research grant payments for Bat Coronavirus Gain of Function work at the Wuhan Institute of Virology”

    • ECOHEALTH | Peter Daszak (2010-2021)

      “Anonymous “Conspiracy” Dossier on Coronavirus SARS-COV2, Peter Daszak Wuhan Virology, Fauci, the NIH/DARPA/Chinese CP Research Timelines”

    • Impact of Health Insurance on Vaccination Coverage (15-Apr-2015)

      “Underinsurance has been a barrier to vaccination among children. Information on vaccination among adults ≥18 years by insurance status is limited |Purpose: To assess vaccination coverage among adults ≥18 years in the United States in 2012 by health insurance status and access to care characteristics”

    • Truman v AMA (16-Jul-1947)

      “The Challenge of National Healthcare as President Truman takes on the American Medical Association in the aftermath of World War II”

    FOOTNOTES

    pandemic footnotes

    All | # A B C D E F H I M N O R S U V W
    There are currently 44 pandemic footnotes in this directory
    1-Sept-2021 @ Clinical Trials Meta Search: Ivermectin

    Results and Latest Published/Pre-Published US Clinical Trials – Meta Search: Ivermectin + Covid-19 @ Search Results for official government authorized trials.






    16-Mar-2020 @ SARS-CoV-2 and COVID-19: Most Important Research Questions

    SARS-CoV-2 and COVID-19: The Most Important Research Questions (16-Mar-2020) @ NIH.GOV link.


    16-Sept-2021 @ ONS: Coronavirus (COVID-19) latest insights: Antibodies

    Coronavirus (COVID-19) latest insights: 90%+ in UK Antibodies + Vaccinated (16-Sept-2021) @ O.N.S. Data official website.


    17-Aug-2021 @ Nasal Saline Irrigation: Hospitalizations in COVID-19 Randomized to Alkalinization or Povidone-iodine

    Rapid initiation of nasal saline irrigation: hospitalizations in COVID-19 patients randomized to alkalinization or povidone-iodine compared to a national dataset (17-Aug-2021) @ MEDRXIV.org paper website link.


    17-Jun-2005 | 22-Aug-2005 | 19-Aug-2008 | 5-May-2018 | 7-Nov-2018 | 16-Mar-2021 | 21-Jun-2021 | 24-Sept-2021 | Various Dodgy Covid-19 Documents

    21-Jun-2021 @ Huge Number of Hospital Workers Still Unvaccinated
    Huge Number of Hospital Workers Still Unvaccinated (21-Jun-2021) @ SITE LINK on vaccines section of webmd.com.


    24-Sept-2021 @ Merck – Owner of Ivermectin – Starts "New" Patent Antiviral Medication Human Trials

    Merck, developer of general antiviral Ivermectin, announcing late stage human trials for a “new” patent medication and oral antiviral drug for COVID-19 (24-Sept-2021) @ ARTICLE on medicalxpress.com pre-publication website.



    4-Aug-2021 @ Expert Reaction to Covid-19 Infection Study

    Expert reaction to the latest fortnightly release on the COVID-19 Infection Survey looking at antibody and vaccination data for the UK (4-Aug-2021) @ LINK to sciencemediacentre.org article.


    6 Months UK Covid-19 Deaths + Hospitalizations (21-Apr-2021 to 21-Oct-2021)
    UK Covid Deaths:
  • 21-Apr-2021: 127,544 total deaths | 11M double vax (6M double vax + fortnight since second dose)
  • 21-Oct-2021: 139,324 total deaths (45M double vax)
  • = 11,780 deaths last 6 months – this is double the average annual flu deaths
  • Hospitalizations | NHS Capacity:
  • 38K hospitalized high point in Jan 2021
  • 8k hospitalized current Covid burden on 21-Oct-2021
  • UK testing @ 1 million a day via all pillars (testing routes)

    6-Jun-2020 @ What Scientists Know About the COVID-19 Virus

    6-Sept-2021 @ DETAILS EMERGE ABOUT CORONAVIRUS RESEARCH AT CHINESE LAB

    More than 900 pages of materials related to US.-funded coronavirus research in China were released following a FOIA lawsuit by The Intercept (6-Sept-2021) @ ARTICLE LINK on theintercept.com website.



    Antiviral Ivermectin In Africa Blocking COVID-19

    August 2021 report on Ivermectin In Africa Blocking COVID-19 on paulcraigroberts.org blog website. Poorer countries are denied access to the vaccines produced in rich nations. Many must tackle Coronavirus using prophylactics and treatment protocols repurposing existing methods like antivirals.




    COVID-19 Antibody Responses: Natural Infection Versus Ad-Vector/mRNA Vaccination

    Natural infection versus vaccination: Differences in COVID antibody responses emerge (24-Aug-2021) @ Study Analysis on rockefeller.edu website.

    The Race to Understand Post–COVID-19 Conditions (31-Aug-2021) @ ACP Journal Link on acpjournals.org website.

    A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity (13-Jul-2012) @ ARTICLE on journals.plos.org website.

    Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike Immunogen: induces potent humoral and cellular immune responses (28-Sept-2020) @ NATURE ARTICLE on nature.com website. See interesting ethics declaration at the end of the article.

    Adenoviral vectors are the new COVID-19 vaccine front-runners: Can they overcome their checkered past? (12-May-2020) @ ACS HYPE ARTICLE on cen.acs.org website.

    Chimpanzee adenoviral vectors as vaccines for outbreak pathogens (30-Oct-2017) @ Peer-Reviewed Article on nih.gov repository.

    Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment (18-Sept-2020) @ STUDY RESULTS on sciencedirect.com website.

    News – Communicating the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine (7-Apr-2021) @ Winton Centre Summary on University of Cambridge website.

    Review of COVID-19 vaccine subtypes, efficacy and geographical distributions (8-May-2021) @ PRE-PUBLISH ARTICLE on BMJ (British Medical Journal) website.


    DEBUNKED: Coronavirus and Blood Donation by American Red Cross – Pfizer, Moderna, J&J, AstraZeneca ALL Eligible (Aug-2021)

    What to know about the Coronavirus and Blood Donation by American Red Cross (Aug-2021) @ Red Cross Website Link.

    “In most cases, there is no deferral time for individuals who received a COVID-19 vaccine as long as they are symptom free and feeling well at the time of donation. There is no deferral time for eligible blood donors who are vaccinated with an inactivated or RNA based COVID-19 vaccine manufactured by AstraZeneca, Janssen/J&J, Moderna, Novavax, or Pfizer.”


    Dec-2019 @ Gilead HIV Drug Profits Price Gouging

    Delta’s Extra $200 Monthly Healthcare Surcharge To Unvaccinated Airline Workers May Have Serious Unintended Consequences

    Profit Squeeze and Cost Distribution For and Against Vaccine Hesitant and Covid-19 ‘Freeloaders’ – Delta’s Extra $200 Monthly Healthcare Surcharge To Unvaccinated Airline Workers May Have Serious Unintended Consequences (28-Aug-2021) @ ARTICLE on the pro-corporate forbes.com website.


    Digital COVID-19 Social Response in Kinshasa (8-Sept-2021)

    Cash and the city: COVID-19 digital social response in Kinshasa, DRC (8-Sept-2021) @ STUDY LINK on Brookings Institute website.


    Dr. Tess Lawrie: The Conscience of Medicine (4-May-2021)

    Early Pandemic Voluntary Insurance Coverage: Cost-sharing Waivers and Premium Relief in US Healthcare

    Cost-sharing waivers and premium relief by private plans in response to COVID-19 in the Early Pandemic (19-Nov-2020) @ SUMMARY ARTICLE on the healthsystemtracker.org website.


    Finland Open-Source Vaccine Ready 2020 – State Funding Withdrawn 2021?
  • Finnish-developed, open-source coronavirus vaccine nearly ready for testing (8-May-2020) @ https://yle.fi/uutiset/osasto/news/finnish-developed_open-source_coronavirus_vaccine_nearly_ready_for_testing/11342151
  • Finnish researchers introduce nasal spray Covid “vaccine” (8-Mar-2021) @ https://www.eurekalert.org/news-releases/776561
  • Future of Finland’s Covid nasal spray vaccine uncertain (7-May-2021) @ https://yle.fi/uutiset/osasto/news/future_of_finlands_covid_nasal_spray_vaccine_uncertain/11921318
  • Ivermectin nasal spray supposedly on patent by Finnish startup Therapeutica Borealis is UNPROVEN (25-Aug-2021) @ https://monitor7.r7.com/aprovado-nos-eua-um-spray-nasal-com-cloroquina-e-ivermectina-25082021

  • Hospitalisations in England 1-Feb-2021 to 29-Aug-2021
    9,472 people were admitted to English hospitals with the highly transmissible Delta variant of coronavirus between 1 February 2021 and 29 August 2021. 5,098 people were under 50.Some 3,742 – or 73 per cent – of the under 50s were unvaccinated. Over 70% of the over 50s were vaccinated.


    Is it OK to put young lives at greater risk for the sake of older lives potentially facing greater risk, e.g. coronavirus caught by grandkids passed on to grandparents?

    CDC data shows very very low risk from Coronavirus vaccines (mRNA or ad-vector) though the chance of serious side effects increases – separate to co-morbidities – for much younger patients, especially males under 21. CDC site numbers give between 5000-1 and 20000-1 serious myocarditis/pericarditis risk for mRNA (Pfizer/Moderna) vaccines, especially after second dose. This risk is far higher than the risk of serious Covid-19, for that age/gender group. Is it OK to put young lives at greater risk for the sake of older lives potentially facing greater risk, e.g. coronavirus caught by grandkids passed on to grandparents?

    Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA Vaccines in Ontario: December 13, 2020 to August 7, 2021 @ Canada Study of 100 Youths Hospitalized after mRNA Vaccination publichealthontario.ca website link.


    Merck’s deadly Vioxx playbook, redux: a debunked smear campaign against its competing drug — Ivermectin (7-Sept-2021)

    “Vioxx” is the name is a smear campaign playbook used by Merck Pharmaceuticals to campaign against its own competing drug—the FDA-approved, Nobel prize-winning antiviral Ivermectin, which is generic, cheap and globally available with very little scope for significant profit. See Merck’s deadly Vioxx playbook redux (7-Sept-2021) @ ARTICLE on TrialSiteNews website documenting corporate malfeasance.


    NIH Admits Gain-of-Function Research with Dr Fauci


    Oxford University: Fungus-derived Anti-cancer Drug Shows Promise

    Reddit Thread Capture from /r/Coronavirus – The Days of Full Covid-19 Coverage Are Over

    The Days of Full Covid-19 Coverage Are Over (20-Sept-2021) @ Reddit Thread from /r/Coronavirus subreddit.


    Seguro Popular: Health Coverage For All in Mexico

    Seguro Popular: Health Coverage For All in Mexico (26-Feb-2015) on the World Bank website.


    University of North Carolina (Chapel Hill) Announces 3D Printed Vaccine Patch

    3D Printed Vaccine Patch Offers Vaccination Without a Shot (24-Sept-2021) @ University of NC announcement in medicalxpress.com website article.


    US Drug Price Extortion Advocated by Pfizer CEO as Democratic Party Pushes Federal Price Negotiation

    Pfizer CEO rallies staff to fight Democrats’ drug price negotiation (22-Sept-2021) @ ARTICLE on politico.com website.


    US FDA Advisory Committee: Pfizer Vaccine "Booster" Meeting

    Vaccines and Related Biological Products Advisory Committee meeting to discuss Pfizer-BioNTech’s supplemental Biologics License Application for administration of a third dose, or “booster” dose, of the COVID-19 vaccine, Comirnaty, in individuals 16 years of age and older


    VeryWellHealth: COVID-19 Vaccine/Treatment/Adverse Effects Insurance?

    VigiAccess gateway to VigiBase: WHO Global Case Safety Database for Medicinal Products
    • VigiBase is the unique WHO global database of individual case safety reports (ICSRs). It is the largest database of its kind in the world
    • VigiAccess launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects of medicinal products

    What’s Gone Wrong in the Fight Against Vaccine Nationalism? Covax Misses 2021 Targets

    Covax Misses its 2021 Delivery Target – What’s Gone Wrong in the Fight Against Vaccine Nationalism? (18-Seot-2021) @ ARTICLE overview on nakedcapitalism.com website.


    Whitney Webb: The Ride of the Biosecurity State on Rokfin

    The Ride of the Biosecurity State – with Whitney Webb on Rokfin (20-Sept-2021) @ ROKFIN VIDEO on Whitney Webb’s Rokfin channel.

    Opportunism

    20+ YEARS OF mRNA TECH FUNDING

    Development of mRNA technology has been in progress for over 20 years, primarily with a view to opening a new deliver mechanism and drug potential for cancer treatments. Various science hurdles had to be overcome; and NIH / DARPA funding drove the research in the US. UK and German government funding equivalents, both importing the technology once the patented messenger RNA delivered in lipid shell mechanism was patented by US Govt. NIH licensed the mRNA tech to public/private companies like BioNtech, Moderna, Cellscript and others.

    GAIN OF FUCTION RESEARCH

    Gain-of-function research has a long controversial history and by the time Obama administration signed off on American labs not doing it, EU had also banned it. China has no such restrictions on risky leading edge medical research.

     

    CHINA AMERICA COLLABORATION

    CCP and Chinese military scientists were brought on board. SARS had hit China. The CCP had been working at research already and was keen to benefit from importing state-of-the-art tech + science. Wuhan Institute of Virology ramped up world leading gain-of-function research and other key internationally sanctioned biological virus science.

    PUBLIC FUNDING - TECH DEV - PRIVATE PROFIT
    • Coronavirus vaccine development – once SARS-CoV2 pandemic was underway – received acceleration funding from two US federal agencies—the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA).
    • Separate channels of American government-military funding (DARPA) and government-civilian science grants (NIH and Fauci) worked out an evolving gain-of-function research collaboration with the Chinese Communist Party and Wuhan Institute of Virology. Trump administration set up ongoing American support.
    MRNA TECHNOLOGY DEVELOPMENT DETAILS

    While mRNA was originally found to be viable for in vivo gene transfer in the early 1990’s, the development of mRNA vaccines was initiated much later due to the inherent instability of mRNA compared to DNA. The efficacy of mRNA vaccines can be increased by several factors, such as ensuring mRNA purity, adding 5’ Kozak and cap sequences, 3’ poly-A sequences and modified nucleosides to increase mRNA stability and decrease detection by the receptors of innate immune cells, codon optimization, introduction by intramuscular, and intradermal injection to reduce RNA degradation, and by generating thermostable mRNA. Methods to encapsulate RNA have also been explored to increase the stability and immunogenicity of RNA vaccines, as has been used with exosome encapsulated RNA and RNA-transfected dendritic cells. When fully optimized, RNA vaccines may have an immunogenic advantage over DNA vaccines due to the presence of multiple cellular pathways that activate innate immunity in response to foreign RNA such as the toll-like receptors (TLRs) and RIG-I-like receptors (RLRs).

    CORONAVIRUS RESEARCH SUMMARY
    • Gain-of-function banned in the US
    • Moved to Wuhan, China
    • Funded by NIH through Ecohealth (Fauci, Dahsak)
    • Wuhan lab used animals for research, including bats
    • In 2019, a novel coronavirus escaped from the Institute of Virology
    • Evidence of infection at World Military Games 2019
    • Major outbreak spread from Wuhan late 2019/early 2020
    • CCP couldn’t contain it, despite authoritarian lockdown and early suppression
    • SARS-Cov2 novel coronavirus went worldwide
    • Covid-19, the disease created by SARS-Cov2, declared pandemic

     

    •  

    Pandemic

    WHO DECLARES PANDEMIC EARLY 2020

    Early 2020. World Health Organisation declares pandemic. Coronavirus goes global. China shares viral genetic codes. Chinese scientists from the Wuhan lab register early Covid-19 vaccine patents along with Moderna and BioNtech-Pfizer.

    WET MARKET NARRATIVE

    Wet market narrative is inserted. China, WHO, CDC, US Govt and others are in lockstep with an official consensus: accidental coronavirus mutation from animals to humans went pandemic, no lab leak, lockdowns across the world to minimize infections, mass media husband public demand for vaccine ASAP.

     

    There’s no evidence Coronavirus was being weaponized by China or that its escape was planned. There’s plenty of evidence Wuhan lab is the source, gain-of-function conditions bred the initial pandemic variant and China was working directly with America through Ecohealth, a front for the NIH/DARPA, run by Dr Fauci and his delegate Dr Dahsak.

    OPERATION WARP SPEED
    • Dr Fauci and military Operation Warp Speed work aggressively to keep messaging consistent (and away from scrutiny of Wuhan Institute of Virology). China is also keen to suppress investigation.
    • Big Tech becomes weaponized to censor dissent from any source, scientist or layperson. YouTube, Twitter, Facebook, Google: hand in glove with government mandate.
    VACCINE EMERGENCY USE AUTHORISATION
    • FDA emergency approval requires there to be no viable available treatment methods. This makes it essential to vaccine profit to squash ANY existing protocol (e.g. ivermectin + steroid + fluvoxamine blend) gaining official recognition. Censorship targets this line of public discussion consistent with Big Pharma/Big Tech/CDC strategy.
    • Alternative prophylaxis and treatment protocols for SARS-CoV2 and Covid-19 – like commonplace diet regimens, Ivermectin – are pushed out of the mainstream, publicly discredited despite growing evidence and clinician support. There’s no profit from off-patent generics. Allowing zero profit medication to play a significant role as a Covid-19 treatment would reduce mRNA vaccine profits by literally tens of billions of dollars.

     

    Much media propagation of the NIH having concluded “there’s currently insufficient data to recommend ivermectin for the treatment of COVID” i.e. don’t use it, don’t explore it. In fact, NIH current status on Ivermectin is there is not enough data to recommend or to discourage its use. NIH recommendation prior to December 2020 was to discourage Ivermectin usage. The change itself is significant and would usually be accompanied by a rush of funds to study its antiviral efficacy. No such funding has been forthcoming.

    Interestingly, two other COVID modalities have exactly the same recommend/discourage status. That would be remdesevir and outpatient monoclonal antibodies. EXACTLY the same status on both of these as ivermectin currently. The NIH states there is not enough evidence to recommend or to discourage the use of either of these. And yet we continue right on with both the others without a blink of an eye.

    A little maths –

    • Ivermectin course for COVID is less than twenty dollars.
    • A course of REMDESEVIR is currently right at 8800 dollars.
    • An outpatient treatment with monoclonal antibodies is right at 23000 – 25000 dollars with all the infusion costs added.

    Eventually, if things keeps looking, smelling and tasting like shit then we have to conclude it is shit.

    TRIALS

    • Trials of vaccines begin early/mid 2020. Stages become truncated to get the vaccines into play at unprecedented timescale.
    • By Stage III (late 2020) the mRNA vaccine trial studies have been designed from the outset to win FDA authorization and return very high efficacy. Authorization of these high-profile high-profit vaccines is pushed through fast. Emergency authorization terms require there to be no other COVID-19 treatment drugs.
    • Emergency Use Authorization of Medical Products and Related Authorities (2017): “For FDA to issue an EUA, there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition” i.e. hydroxychloroquine and ivermectin must stay unapproved and discredited.

     

    TRIAL PRESS RELEASES

    Based on data reported by the manufacturer for Pfzier/BioNTech vaccine BNT162b2, this critical appraisal shows: relative risk reduction, 95.1%; 95% CI, 90.0% to 97.6%; p = 0.016; absolute risk reduction, 0.7%; 95% CI, 0.59% to 0.83%; p < 0.000. For the Moderna vaccine mRNA-1273, the appraisal shows: relative risk reduction, 94.1%; 95% CI, 89.1% to 96.8%; p = 0.004; absolute risk reduction, 1.1%; 95% CI, 0.97% to 1.32%; p < 0.000. Unreported absolute risk reduction measures of 0.7% and 1.1% for the Pfzier/BioNTech and Moderna vaccines, respectively, are very much lower than the reported relative risk reduction measures. Reporting absolute risk reduction measures is essential to prevent outcome reporting bias in evaluation of COVID-19 vaccine efficacy.

    BIG PHARMA BIG PROFIT
    • Moderna (m—-RNA) in Cambridge MA start-up launched to monetize public-private partnership
    • Pfizer exclusive partnership with German funded BioNTech
    • AstraZeneca licenses Oxford University developed vaccine for Coronavirus with a zero-profit agreement

     

    PROFITS

    • Big Pharma, having already entered into contracts to deliver billions of vaccine doses, spends millions on the groundwork – in mainstream media, government CDC, etc – to guide public pandemic expectations. They achieve unprecedented demand from national vaccine programs across the world.
    • Pfizer and Moderna (in particular) are focused on harvesting hundreds of billions of dollars profit, potentially trillions if their vaccines need to be taken every year.
    TRUMP BIDEN BULLSHIT
    • Trump administration is both incompetent and luddite about coronavirus. When Covid-19 can no longer be ignored, Trump stubbornly doubles down on bullish politicized denialism, eschewing federalized strategy in favor of dropping organizing lockdown, quarantine, testing, treatment and vaccine deployment into the state by state red-v-blue internecine.
    • Establishment takes advantage of the Trump posture to arrange an opposing politics-led exclusive orthodoxy behind Fauci and CDC expertise: lockdowns, masks, censorship for public good, furloughs, vaccine programs, trillions of dollars transferred to corporate clients, etc.
    • Vaccine data, focus of media reportage, official bulletins from Fauci and then Biden administration continue the orthodox narrative. There’s no let up on aggressive censorship of anything and anyone diverging from official CDC directive. Periodic numbers published about near-perfect efficacy of vaccines. Variants used to obfuscate closer inspection of data

     

    TRUMP OUT BIDEN IN

    • Democratic Party has won Presidency, Senate, House of Reps. Big tech is playing ball. Big Pharma is making billions. Corporate America has emerged wealthier. They have dropped the economic hit this far on the middle and working class. Progressive opposition has been castrated.
    • Biden is distanced enough from Fauci, schmoozing abroad, playing up Putin and Chinese threat while business as usual plutocracy trundles into the second half of 2021.
    CLICKBAIT AND FEARPORN

    Relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data are poorly understood by health professionals and the public. The absence of reported absolute risk reduction in COVID-19 vaccine clinical trials can lead to outcome reporting bias that affects the interpretation of vaccine efficacy.  What’s more, trial data is limited by short time period reporting that don’t take into account increase or decrease in efficacy outside the short window of back to back testing.

    Bottom Line

    TRILLIONS OF DOLLARS

    Trillions of dollars are at stake, for corporate and treasury revenue, particularly in the United States and the United Kingdom/European Union. This will ensure American govt and its corporate clients will continue to exert their tight hold on the Coronavirus narrative.

     

    COST/PRICING

  • Remdesivir: 340UKP Dose Cost in the United Kingdom
  • CENSORSHIP

    Expect censorship to continue, subjects diversifying according to government priority as directed by vaccine makers and political expedience. Big tech regulation is a stick to beat platforms into submission, taxation a clear and present penalty for forcing corporations or billionaire CEOs to play ball.

     

    TRANSGRESSIVES

    Expect transgressions that risk profit or power to be punished with increasing force. Too much money and too many powerful people have staked their future on the current Coronavirus Political-Industrial complex. Expect genuine alternate prevention and treatment to be marginalized.  Will there be a paradigm shift? Look for testing standards that never coalesce and vaccine approval bias that continue to choose profit over lives e.g. American FDA not letting no-profit AstraZeneca ad-vector into the US market.

    THE BULLSHIT SPIGOT

    Expect shifting standards in the media shilling for vaccine and vaccine mandates as efficacy data becomes less falsifiable real-world but maximum profit will inform the narrative e.g. if vax doesn’t protect fully, look for propaganda about extra/regular shots, excuses like “the virus mutated” etc.

    Directories

    Infomedia

    American CDC Influenza Data (2018):

    World Health Organization Annual Influenza:

    Wirts mirt bud?

    0